Kim Bojstrup Jensen

Title: Kim Bojstrup Jensen: Innovator in Pharmaceutical Composition

Introduction

Kim Bojstrup Jensen is a notable inventor based in Kobenhavn O, Denmark. He has made significant contributions to the field of pharmaceuticals, particularly in the development of crystalline compositions. His work has led to advancements that enhance the efficacy and manufacturing processes of pharmaceutical products.

Latest Patents

Kim Bojstrup Jensen holds a patent for a crystalline composition containing escitalopram. The patent discloses crystalline particles of escitalopram oxalate, which either have a broad particle size distribution or comprise at least 0.01% (w/w) of Z-4-(4-dimethylamino-1-(4-fluorophenyl)-but-1-enyl)-3-hydroxymethyl-benzonitrile. These particles are suitable for use in direct compression. Additionally, the invention includes a novel pharmaceutical unit dosage form containing such crystalline particles and methods for their manufacture. Furthermore, it provides a method for reducing the amount of hydroxyl-containing impurities in a solution of citalopram or escitalopram.

Career Highlights

Kim Bojstrup Jensen is associated with H. Lundbeck A/S, a prominent company in the pharmaceutical industry. His work at Lundbeck has been instrumental in advancing the company's research and development efforts in mental health medications.

Collaborations

Throughout his career, Kim has collaborated with notable colleagues, including Rikke E Humble and Ken Liljegren. These collaborations have contributed to the successful development of innovative pharmaceutical solutions.

Conclusion

Kim Bojstrup Jensen's contributions to the field of pharmaceuticals, particularly through his patent on escitalopram compositions, highlight his role as an innovator in the industry. His work continues to impact the development of effective treatments for mental health conditions.